Delivery Order SPE2DB20D3505-SPE2DB25FT2Z1
- Not listed
- This federal contract award, valued at $1,430.89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ramelteon 8 mg tablets, a sleep medication, and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,508.63 firm fixed-price delivery order is for the supply of RAMELTEON 8 MG TABLET 30S, a medication used to treat insomnia. The award is not designated under any set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ramelteon 8 mg tablets in unit dose packaging (50 count) with a firm fixed price ceiling value of $2,669.48. This non-set-aside competitive award is scheduled for completion by August 5, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,619.95, is for the delivery of RAMELTEON 8 MG TABLET UD 50S, a medication used to treat insomnia. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 2, 2025. The contract does not have a set-aside designation,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $5,286.88, to provide RAMELTEON 8 MG TABLET 100S to the government. The contract has an ultimate completion date of July 11, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,095.54 to AmerisourceBergen Drug Corp for Ramelteon 8 mg tablets (30-count supply) on August 22, 2025, with completion targeted for August 25, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Ramelteon is a prescription sleep aid medication used in the treatment of insomnia, reflecting the Defense...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $89,490 to Amerisourcebergen Drug Corporation to supply 4561368131 Ramelteon 8 mg tablets. As the prime contractor, Amerisourcebergen will deliver 30 units of the specified pharmaceutical to a facility in Conshohocken, Pennsylvania, under a contract running from June 28 through June 29, 2023. The order is funded through the Defense Logistics Agency's pharmaceutical procurement programs and is not designated for...
- This delivery order for $349 was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp for 30 tablets of 8 mg ramelteon. The order is for product delivery by October 18, 2023 under a firm fixed price contract. Amerisourcebergen Drug Corp will perform the order from its location in Conshohocken, Pennsylvania. No set-aside provision was specified for this order placed under an existing vehicle by the Defense Logistics Agency to fulfill pharmaceutical needs for the military.
- This federal contract award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply a range of medical products including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,102.36 firm-fixed-price delivery order is for the supply of Ambien CR 6.25 mg tablets, a medication used for the treatment of insomnia. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FT2Z1Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,432.06 firm-fixed-price delivery order provides 4566170446 ramelteon 8 mg tablets to support military healthcare programs. The award has an ultimate completion date of October 22, 2024 and was issued on October 21, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. This delivery order is not designated with a set-aside requirement, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 10/21/24 |